Application of mupirocin cream at the catheter exit site reduces exit-site infections and peritonitis in peritoneal dialysis patients

被引:0
|
作者
Casey, M [1 ]
Taylor, J
Clinard, P
Graham, A
Mauck, V
Spainhour, L
Brown, P
Burkart, J
机构
[1] Wake Forest Univ, Sch Med, Nephrol Sect, Winston Salem, NC 27109 USA
[2] Piedmont Dialysis Ctr Inc, Winston Salem, NC USA
来源
PERITONEAL DIALYSIS INTERNATIONAL | 2000年 / 20卷 / 05期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:566 / 568
页数:3
相关论文
共 50 条
  • [31] KOCURIA SPP AS RESPONSIBLE FOR PERITONITIS AND EXIT-SITE INFECTIONS IN PATIENTS IN A PERITONEAL DIALYSIS UNIT IN MEDELLIN, COLOMBIA
    Martinez Marin, Maria I.
    Villegas Gutierrez, Ivan
    Quintero Higuera, Edwin
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [32] THE EFFECT OF EXIT-SITE ANTIBACTERIAL HONEY VERSUS NASAL MUPIROCIN PROPHYLAXIS ON THE MICROBIOLOGY AND OUTCOMES OF PERITONEAL DIALYSIS-ASSOCIATED PERITONITIS AND EXIT-SITE INFECTIONS: A SUB-STUDY OF THE HONEYPOT TRIAL
    Zhang, Lei
    Badve, Sunil V.
    Pascoe, Elaine M.
    Beller, Elaine
    Cass, Alan
    Clark, Carolyn
    de Zoysa, Janak
    Isbel, Nicole M.
    McTaggart, Steven
    Morrish, Alicia T.
    Playford, E. Geoffrey
    Scaria, Anish
    Snelling, Paul
    Vergara, Liza A.
    Hawley, Carmel M.
    Johnson, David W.
    PERITONEAL DIALYSIS INTERNATIONAL, 2015, 35 (07): : 712 - 721
  • [33] POOR COMPLIANCE OF EXIT-SITE CARE AND CATHETER IMMOBILIZATION WERE THE RISK FACTORS OF EXIT-SITE INFECTION IN INCIDENT PERITONEAL DIALYSIS PATIENTS
    Lin, J.
    Yang, X.
    Lu, S.
    Chen, J.
    Yu, X.
    Yi, C.
    Wu, X.
    Zhang, X.
    Guo, Q.
    Yu, X.
    NEPHROLOGY, 2016, 21 : 161 - 161
  • [34] PROPHYLAXIS FOR PERITONEAL EXIT SITE INFECTIONS WITH MUPIROCIN
    Venuthurupalli, S.
    Williams, L.
    Ranganathan, D.
    NEPHROLOGY, 2009, 14 : A23 - A23
  • [35] EXIT-SITE AND TUNNEL INFECTIONS IN CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS PATIENTS
    SCALAMOGNA, A
    CASTELNOVO, C
    DEVECCHI, A
    PONTICELLI, C
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 18 (06) : 674 - 677
  • [36] CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS (CAPD) PERITONITIS AND EXIT-SITE INFECTIONS - CHALLENGES FOR THE FUTURE
    KEANE, WF
    EVERETT, ED
    FINE, RN
    GOKAL, R
    GOLPER, TA
    MATZKE, GR
    PETERSON, PK
    VAS, S
    PERITONEAL DIALYSIS INTERNATIONAL, 1989, 9 (04): : 239 - 240
  • [37] Computed tomography for the management of exit-site and tunnel infections in peritoneal dialysis patients
    Nozaki, Keina
    Kamijo, Yuka
    Nakatsuka, Mineo
    Azuma, Takeshi
    Nakagawa, Tohru
    Miyazaki, Hideyo
    Fujimura, Tetsuya
    Fukuhara, Hiroshi
    Kume, Haruki
    Ishibashi, Yoshitaka
    Homma, Yukio
    CLINICAL NEPHROLOGY, 2016, 86 (06) : 328 - 332
  • [38] COMPARISON OF TOPICAL CHLORHEXIDINE AND MUPIROCIN FOR THE PREVENTION OF EXIT-SITE INFECTION IN INCIDENT PERITONEAL DIALYSIS PATIENTS
    Htay, Htay
    Johnson, David W.
    Wu, Sin Yan
    Oei, Elizabeth Ley
    Foo, Marjorie Wai Yin
    Choo, Jason Chon Jun
    PERITONEAL DIALYSIS INTERNATIONAL, 2017, 37 (03): : 266 - 272
  • [39] FREQUENCY AND MICROBIOLOGY OF PERITONITIS AND EXIT-SITE INFECTION AMONG OBESE PERITONEAL DIALYSIS PATIENTS
    Nessim, Sharon J.
    Komenda, Paul
    Rigatto, Claudio
    Verrelli, Mauro
    Sood, Manish M.
    PERITONEAL DIALYSIS INTERNATIONAL, 2013, 33 (02): : 167 - 174
  • [40] Mupirocin application at the exit site in peritoneal dialysis patients: five years of experience
    Aykut, Sifil
    Caner, Cavdar
    Ozkan, Gungor
    Ali, Celik
    Tugba, Atay
    Zeynep, Gulay
    Taner, Camsari
    RENAL FAILURE, 2010, 32 (03) : 356 - 361